Matches 1 - 50 out of 117 1 2 3 >


Match Document Document Title
US20110318265 Coupled identification and treatment of cancer  
Provided are methods to treat cancer in which a patient is identified as having gallium-avid cancer by use of a gallium scan or other means, and is then treated with a pharmaceutically acceptable...
US20140093451 Coupled identification and treatment of cancer  
Provided are methods to treat cancer, in which (1) a patient is first identified as having a cancer that is likely to be susceptible to gallium therapy, by the use of a gallium scan or other...
US20100168554 Evaluating Cardiac Function With Dynamic Imaging Techniques and Contrast Media  
Methods suitable for use in diagnostic imaging or to generate a central circulatory turnover (CCT) index for an evaluation of cardiac function of a patient are provided. The resultant CCT index...
US20120315217 INVERSE AGONISTS AND NEUTRAL ANTAGONISTS FOR THE TSH RECEPTOR  
TSHR inverse agonists and neutral antagonists that are useful for treating Graves' orbitopathy, Graves' hyperthyroidism and/or thyroid cancer.
US20150125387 DISTINGUISHING BENIGN AND MALIGNANT INDETERMINATE THYROID LESIONS  
The application describes methods for accurately evaluating whether thyroid test samples, especially indeterminate thyroid samples, are benign or malignant.
US20140099261 DISTINGUISHING BENIGN AND MALIGNANT INDETERMINATE THYROID LESIONS  
The application describes methods for accurately evaluating whether thyroid test samples, especially indeterminate thyroid samples, are benign or malignant.
US20130302244 METHOD OF PREPARING IODINE SEED FOR TREATING EYE DISEASE OR CANCER, AND IODINE SEED PREPARED THEREBY  
The present invention provides a technique for adsorbing I-125 on a support for treating cancer and a method of preparing an I-125 seed using the same. Since a method of preparing iodine according...
US20120251442 Methods for Treatment of Tumors by Direct Administration of a Radioisotope  
This invention provides a safer and more effective treatment for non-intracavitary undesirable tissue masses, especially bone cancer and soft tissue tumors. The method involves the direct...
US20120282179 Methods of Using C-Met Modulators  
Methods of treating cancer by administering a compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof, in combination with other cancer treatments are described, wherein R1...
US20150118495 STRONTIUM PHOSPHATE MICROPARTICLE FOR RADIOLOGICAL IMAGING AND THERAPY  
This invention relates to strontium-phosphate microparticles that incorporate radioisotopes for radiation therapy and imaging.
US20140335017 STRONTIUM PHOSPHATE MICROPARTICLE FOR RADIOLOGICAL IMAGING AND THERAPY  
This invention relates to strontium-phosphate microparticles that incorporate radioisotopes for radiation therapy and imaging.
US20120232325 RADIOACTIVE BONE CEMENT  
Methods are described for treating a target tissue with a radioisotope. Some methods include determining a distance between a target tissue and a surface of a matrix material to be positioned...
US20140134104 CANCER THERAPY  
The invention provides a method of treating a tumor or other lesion comprising introducing a solution comprising one or more radioactive isotopes directly into said tumour or other lesion in a...
US20120095324 METHOD FOR A NUCLEAR MEDICINE EXAMINATION  
A method for a nuclear medicine examination of a patient is disclosed. In at least one embodiment of the method, a magnetic resonance recording of an examination region of the patient is created...
US20140341803 STABLE NANOEMULSIONS USEFUL IN THE TREATMENT OF CANCER  
Described herein are methods for treating a tumor or cancer in a subject. The methods involve administering to the subject a nanoemulsion comprising (1) at least one perfluoro crown ether and (2)...
US20150118155 COMPOSITIONS AND METHODS FOR DIAGNOSING AND MONITORING HYPERTHYROIDISM IN A FELINE  
The present invention provides a method of diagnosing the existence or risk of hyperthyroidism in a feline comprising measuring the level of expression of one or more biomarkers selected from the...
US20120276004 HUMAN MYELOID DERIVED SUPPRESSOR CELL CANCER MARKERS  
Provided herein are methods for determining the presence of cancer (malignant versus benign), monitoring the progression of cancer, monitoring cancer relapse, monitoring the response to cancer...
US20130004418 INFILTRATION SOLUTION FOR TREATING AN ENAMEL LESION  
The invention relates to an infiltration solution of a radiopaque metal compound for treating an enamel lesion, to a kit for dental application, and to the use thereof for preventing and/or...
US20110038792 INDUCTION OF THYROID IODIDE-HANDLING GENE EXPRESSION IN HUMAN CANCERS  
Dual suppression of the MAP kinase and PI3K/Akt pathways showed synergistic or greatly enhanced anti-melanoma cell effects, compared to suppression of a single pathway, including the inhibition of...
US20140079630 CARBON NANOTUBES FOR IMAGING AND DRUG DELIVERY  
The invention provides compositions and methods for visualizing particular tissues and delivering one or more therapeutics to that tissue using single-walled carbon nanotubes (SWNTs), which are...
US20090257949 Radiopharmaceutical Imaging of Neurodegenerative Diseases  
Methods for simultaneously detecting dementia or cognitive impairment, such as Alzheimer's Disease (AD), Parkinson's Disease (PD), Lewy Body Dementia (LBD) and Vascular Dementia (VaD) in a patient...
US20120027675 TARGETING PULMONARY EPITHELIUM USING ADRP  
This invention provides novel compositions and methods for the specific and/or preferential delivery of an effector (e.g. a drug or label) to an epithelial cell (e.g. a pulmonary epithelium). The...
US20110064655 BIOMARKERS FOR DEPRESSION  
Differential expression of nucleic acids in the brains of subjects suffering from late-onset depression has been demonstrated. The invention provides methods useful in the determination of...
US20110104249 Oncotherapeutic Application of Inhibitors of High-Affinity Glucose Transporters  
The subject invention concerns materials and methods for treating oncological disorders in a person or animal using any agent or compound that inhibits uptake of glucose into a cell. The subject...
US20150202337 IRON GARNET NANOPARTICLES FOR CANCER RADIOTHERAPY AND CHEMOTHERAPY  
Iron garnet nanoparticles and or iron garnet particles containing various activatable nuclides, such as holmium-165(165Ho) and dysprosium-164 (164Dy), are disclosed in this application. The iron...
US20110229408 SODIUM-IODIDE SYMPORTER GENE REPRESSOR BINDING SITE  
The present disclosure relates to a sodium iodide symporter (NIS)-repressor binding sites (NRBS) consensus sequence consisting of a DNA molecule having the sequence...
US20060204436 Tritiated growth hormone secretagogue mk-0677  
The present invention relates to a tritiated growth hormone secretagogue which can be used for the identification of compounds capable of binding to growth hormone secretagogue receptors, or of...
US20110044897 METHOD OF IMAGING LOCALIZED INFECTIONS  
The invention relates to a method for targeting an imaging agent to cells of an animal to detect localized infections. More particularly, localized infections are detected by targeting imaging...
US20090297442 RADIOPHARMACEUTICAL PRODUCTS  
The present invention relates to improved radiopharmaceutical compositions in sealed containers, where the container closure has an ETFE (ethylene-tetrafluoroethylene copolymer) coating. Also...
US20110123445 TREATMENT MONITORING  
The present invention provides a method for monitoring the effectiveness of atreatment, wherein said treatment comprises an inhibitor designed to treat a disease comprising abnormal activity of...
US20120082616 Aptamer Conjugates for Targeting of Therapeutic and/or Diagnostic Nanocarriers  
The present invention provides targeted delivery compositions and their methods of use in treating and diagnosing a disease state in a subject.
US20110129417 ADMINISTRABLE COMPOSITIONS  
The present invention relates to a composition suitable for administration to a subject, the composition comprising pharmacologically acceptable particulate material dispersed throughout a...
US20140356282 100Mo compounds as accelerator targets for production of 99mTc  
Methods of synthesizing 100Mo2C and 99mTcO4− are disclosed. Methods of 100Mo2C generation involve thermally carburizing 100MoO3. Methods of 99mTcO4 generation involve proton bombardment of 100Mo2C...
US20130052129 METHOD FOR MONITORING BLOOD FLOW AND METABOLIC UPTAKE IN TISSUE WITH RADIOLABELED ALKANOIC ACID  
The present invention relates to novel modified fatty acid analogs, where a positron or gamma-emitting label is placed at a position on a fatty acid backbone and an organic substituent is...
US20140193335 DEVICES AND METHODS FOR THE TREATMENT OF CANCER  
The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a...
US20120076723 DEVICES AND METHODS FOR THE TREATMENT OF CANCER  
The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a...
US20070248540 Biochemical methods for measuring metabolic fitness of tissues or whole organisms  
The present invention relates to biochemical methods for assessing metabolic fitness and/or aerobic demands of a living system. Specifically, the rate of synthesis and turnover of the molecular...
US20140199236 ANDROGEN RECEPTOR MODULATOR AND USES THEREOF  
Described herein is the androgen receptor modulator of formula (I) in the treatment of prostate cancer in combination with other therapeutic options and in the treatment of diseases or conditions...
US20080226549 BREAST CANCER ERADICATION PROGRAM  
A method of treating breast cancer that is at least partially ER+ is disclosed. The method comprises administering at a tumor site in a mammalian subject a pharmaceutically acceptable form of...
US20090246126 Thulium-based capsule and devices for use in high dose rate brachytherapy  
A capsule for high dose rate brachytherapy, wherein the capsule comprises within its interior space thulium-170, and further comprises at least one layer of a radiation emission modifying metal...
US20100150830 METHOD OF TREATING CANCER  
A method and composition for administering a therapeutic agent to a lesion comprising a contrast/carrier agent and ethanol.
US20100196268 Compositions and methods for treatment of tumors by direct administration of a radioisotope  
This invention provides a safer and more effective treatment for non-intracavitary undesirable tissue masses, especially bone cancer and soft tissue tumors. The method involves the direct...
US20120276003 COMPOUND CONTAINING AN OXYGEN-15, PREPARATION AND USE THEREOF, AND COMPOSITION COMPRISING THEREOF  
The present disclosure relates to a compound comprising an oxygen-15 and a process for preparation thereof. It also relates to the use of the compound in positron and/or other nuclide imaging and...
US20090202434 Pharmaceutical Composition and Dressing for Treating Skin Lesion, as Well as the Use of Cerium Salt Associated With a Collagen Matrix  
The present invention refers to a pharmaceutical composition for treating skin lesion, comprising a cerium salt on a collagen matrix and a dermatologically acceptable carrier. The present...
US20080187489 Generator and Method for Production of Technetium-99m  
A generator that allows for a non-fission based method of producing and recovering 99mTc from neutron-irradiated molybdenum. This generator system is based on the isolation of 99mTc, as the decay...
US20100303719 ANTI-CANCER COMPOUNDS  
The present invention relates to anti-cancer compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides analogs of the known anti-cancer...
US20120213700 COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN  
The subject invention relates to the compositions for radiolabeling Diethylenetriaminepentaacetic Acid (DTPA)-dextran with Technetium-99m and for stabilizing the DTPA-dextran Cold Kit. The...
US20090324493 METHOD FOR PREPARING A SALINE SOLUTION COMPRISING [13N] NH4 + AND USE OF A DEVICE  
The invention relates to a method for preparing a saline solution comprising [13N]NH4+. The method comprises following steps: preparing [13N]NH3 gas, transporting [13N]NH3 gas to a diffusion...
US20100143247 DIAGNOSIS OF PROSTATE CANCER  
The present invention provides a method for determining the presence of prostate cancer in a subject which method comprises determining the level of expression of one or more markers in a blood...
US20080003177 Radioactive arsenic-containing compounds and their uses in the treatment of tumors  
This invention provides a process for producing a radioactive arsenic-containing compound, comprising the steps of: (i) subjecting an arsenic-containing compound to a neutron irradiation...

Matches 1 - 50 out of 117 1 2 3 >